A Phase I placebo-controlled Study of PepGNP-ChikV in Healthy Volunteers

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1013539

• Contact name

  BRADLEY NORTON

• Contact email

  info@gyldenpharma.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - Riverside Research Ethics Committee

• REC reference

  26/LO/0179

• Date of REC Opinion

  1 May 2026

• REC opinion

  Further Information Favourable Opinion